Genetic analysis of multiple sclerosis in Europeans

Journal of Neuroimmunology

Volumn 143, Issue 1-2, 2003, Pages 1-6

  Barcellos, Lisa F ^a,b   Thomson, Glenys ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HLA DR2 ANTIGEN;

ALLELE; CHROMOSOME 6P; CONFERENCE PAPER; EUROPE; GENE LOCUS; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROSATELLITE MARKER; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0142155200     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.08.004     Document Type: Conference Paper

References (76)

1. Akesson E., Oturai A., Berg J., Fredrikson S., Andersen O., Harbo H.F.et al. A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immun. 3:2002;279-285.
2. Allen M., Sandberg-Wollheim M., Sjogren K., Erlich H.A., Petterson U., Gyllensten U. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum. Immunol. 39:1994;41-48.
3. Ban M., Stewart G.J., Bennetts B.H., Heard R., Simmons R., Maranian M.et al. A genome screen for linkage in Australian sibling-pairs with multiple sclerosis. Genes Immun. 3:2002;464-469.
4. Bansal A., van den Boom D., Kammerer S., Honisch C., Adam G., Cantor C.R.et al. Association testing by DNA pooling: an effective initial screen. Proc. Natl. Acad. Sci. U. S. A. 99:2002;16871-16874.
5. Barcellos L.F., Klitz W., Field L.L., Tobias R., Bowcock A.M., Wilson R.et al. Association mapping of disease loci, by use of a pooled DNA genomic screen. Am. J. Hum. Genet. 61:1997;734-747.
6. Barcellos L.F., Thomson G., Carrington M., Schafer J., Begovich A.B., Lin P.et al. Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese patients [see comments]. Jama. 278:1997;1256-1261.
7. Barcellos L.F., Oksenberg J.R., Green A.J., Bucher P., Rimmler J.B., Schmidt S.et al. Genetic basis for clinical expression in multiple sclerosis. Brain. 125:2002;150-158.
8. Barcellos L.F., Oksenberg J.R., Begovich A.B., Martin E.R., Schmidt S., Vittinghoff E.et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am. J. Hum. Genet. 72:2003;710-716.
9. Barratt B.J., Payne F., Rance H.E., Nutland S., Todd J.A., Clayton D.G. Identification of the sources of error in allele frequency estimations from pooled DNA indicates an optimal experimental design. Ann. Hum. Genet. 66:2002;393-405.
10. Botstein D., Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat. Genet. 33:2003;228-237. (Suppl.).
11. Brassat D., Azais-Vuillemin C., Yaouanq J., Semana G., Reboul J., Cournu I.et al. Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group. Neurology. 52:1999;1632-1636.
12. Broadley S., Sawcer S., D'Alfonso S., Hensiek A., Coraddu F., Gray J.et al. A genome screen for multiple sclerosis in Italian families. Genes Immun. 2:2001;205-210.
13. Chen J., Germer S., Higuchi R., Berkowitz G., Godbold J., Wetmur J.G. Kinetic polymerase chain reaction on pooled DNA: a high-throughput, high-efficiency alternative in genetic epidemiological studies. Cancer Epidemiol. Biomark. Prev. 11:2002;131-136.
14. Collins H.E., Li H., Inda S.E., Anderson J., Laiho K., Tuomilehto J., Seldin M.F. A simple and accurate method for determination of microsatellite total allele content differences between DNA pools. Hum. Genet. 106:2000;218-226.
15. Coraddu F., Sawcer S., D'Alfonso S., Lai M., Hensiek A., Solla E.et al. A genome screen for multiple sclerosis in Sardinian multiplex families. Eur. J. Hum. Genet. 9:2001;621-626.
16. Daly M.J., Rioux J.D., Schaffner S.F., Hudson T.J., Lander E.S. High-resolution haplotype structure in the human genome. Nat. Genet. 29:2001;229-232.
17. Daniels J., Holmans P., Williams N., Turic D., McGuffin P., Plomin R., Owen M.J. A simple method for analyzing microsatellite allele image patterns generated from DNA pools and its application to allelic association studies. Am. J. Hum. Genet. 62:1998;1189-1197.
18. Daniels J., McGuffin P., Owen M.J., Plomin R. Molecular genetic studies of cognitive ability. Hum. Biol. 70:1998;281-296.
19. Ebers G.C., Sadovnick A.D., Risch N.J. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group [see comments]. Nature. 377:1995;150-151.
20. Ebers G.C., Kukay K., Bulman D.E., Sadovnick A.D., Rice G., Anderson C. et al. A full genome search in multiple sclerosis [see comments]. Nat. Genet. 13:1996;472-476.
21. Eraksoy M., Hensiek A., Kurtuncu M., Akman-Demir G., Kihnc M., Gedizlioglu M.et al. A genome screen for linkage disequilibrium in Turkish multiple sclerosis. J. Neuroimmunol. 143:2003;129-132. (this issue).
22. Eraksoy M., Kurtuncu M., Akman-Demir G., Kilinc M., Gedizlioglu M., Mirza M.et al. A whole genome screen for linkage in Turkish multiple sclerosis. J. Neuroimmunol. 143:2003;17-24. (this issue).
23. Fogdell-Hahn A., Ligers A., Gronning M., Hillert J., Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease [In Process Citation]. Tissue Antigens. 55:2000;140-148.
24. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B.et al. The structure of haplotype blocks in the human genome. Science. 296:2002;2225-2229.
25. Germer S., Holland M.J., Higuchi R. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res. 10:2000;258-266.
26. Haines J.L., Ter-Minassian M., Bazyk A., Gusella J.F., Kim D.J., Terwedow H.et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group [see comments]. Nat. Genet. 13:1996;469-471.
27. Haines J.L., Terwedow H.A., Burgess K., Pericak-Vance M.A., Rimmler J.B., Martin E.R.et al. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum. Mol. Genet. 7:1998;1229-1234.
28. Hauser S., Goodkin D. Multiple sclerosis. Braunwald E., Fauci A.S., Kasper D.L., Hauser S.L., Longo D.L., Jameson J.L. Harrison's Principles of Internal Medicine. 2001;2452-2461 McGraw Hill, New York.
29. Holloway J.W., Beghe B., Turner S., Hinks L.J., Day I.N., Howell W.M. Comparison of three methods for single nucleotide polymorphism typing for DNA bank studies: sequence-specific oligonucleotide probe hybridisation, TaqMan liquid phase hybridisation, and microplate array diagonal gel electrophoresis (MADGE). Human Mutat. 14:1999;340-347.
30. Hoogendoorn B., Owen M.J., Oefner P.J., Williams N., Austin J., O'Donovan M.C. Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography. Hum. Genet. 104:1999;89-93.
31. Kantarci O.H., de Andrade M., Weinshenker B.G. Identifying disease modifying genes in multiple sclerosis. J. Neuroimmunol. 123:2002;144-159.
32. Kelly J.A., Thompson K., Kilpatrick J., Lam T., Nath S.K., Gray-McGuire C.et al. Evidence for a susceptibility gene (SLEH1) on chromosome 11q14 for systemic lupus erythematosus (SLE) families with hemolytic anemia. Proc. Natl. Acad. Sci. U. S. A. 99:2002;11766-11771.
33. Kirov G., Williams N., Sham P., Craddock N., Owen M.J. Pooled genotyping of microsatellite markers in parent-offspring trios. Genome Res. 10:2000;105-115.
34. Kuokkanen S., Gschwend M., Rioux J.D., Day M.J., Terwilliger J.D., Tienari P.J.et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. 61:1997;1379-1387.
35. Lander E.S. The new genomics: global views of biology. Science. 274:1996;536-539.
36. LeDuc C., Miller P., Lichter J., Parry P. Batched analysis of genotypes. PCR Methods Appl. 4:1995;331-336.
37. Marrosu M.G., Murru R., Murru M.R., Costa G., Zavattari P., Whalenet al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum. Mol. Genet. 10:2001;2907-2916.
38. Marth G., Yeh R., Minton M., Donaldson R., Li Q., Duan S.et al. Single-nucleotide polymorphisms in the public domain: how useful are they? Nat. Genet. 27:2001;371-372.
39. Mohlke K.L., Erdos M.R., Scott L.J., Fingerlin T.E., Jackson A.U., Silander K.et al. High-throughput screening for evidence of association by using mass spectrometry genotyping on DNA pools. Proc. Natl. Acad. Sci. U. S. A. 99:2002;16928-16933.
40. Namjou B., Nath S.K., Kilpatrick J., Kelly J.A., Reid J., James J.A., Harley J.B. Stratification of pedigrees multiplex for systemic lupus erythematosus and for self-reported rheumatoid arthritis detects a systemic lupus erythematosus susceptibility gene (SLER1) at 5p15.3. Arthritis Rheum. 46:2002;2937-2945.
41. Namjou B., Nath S.K., Kilpatrick J., Kelly J.A., Reid J., Reichlin M., James J.A., Harley J.B. Genome scan stratified by the presence of anti-double-stranded DNA (dsDNA) autoantibody in pedigrees multiplex for systemic lupus erythematosus (SLE) establishes linkages at 19p13.2 (SLED1) and 18q21.1 (SLED2). Genes Immun. 3(Suppl. 1):2002;S35-S41.
42. Nath S.K., Kelly J.A., Namjou B., Lam T., Bruner G.R., Scofield R.H.et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am. J. Hum. Genet. 69:2001;1401-1406.
43. Nath S.K., Kelly J.A., Reid J., Lam T., Gray-McGuire C., Namjou B., Aston C.E., Harley J.B. SLEB3 in systemic lupus erythematosus (SLE) is strongly related to SLE families ascertained through neuropsychiatric manifestations. Hum. Genet. 111:2002;54-58.
44. Norton N., Williams N.M., Williams H.J., Spurlock G., Kirov G., Morris D.W.et al. Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools. Hum. Genet. 110:2002;471-478.
45. Patil N., Berno A.J., Hinds D.A., Barrett W.A., Doshi J.M., Hacker C.R. et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science. 294:2001;1719-1723.
46. Pericak-Vance M.A., Rimmler J.B., Martin E.R., Haines J.L., Garcia M.E., Oksenberg J.R.et al. Linkage and association analysis of chromosome 19q13 in multiple sclerosis. Neurogenetics. 3:2001;195-201.
47. Perlin M.W., Lancia G., Ng S.K. Toward fully automated genotyping: genotyping microsatellite markers by deconvolution. Am. J. Hum. Genet. 57:1995;1199-1210.
48. Plomin R., Hill L., Craig I.W., McGuffin P., Purcell S., Sham P.et al. A genome-wide scan of 1842 DNA markers for allelic associations with general cognitive ability: a five-stage design using DNA pooling and extreme selected groups. Behav. Genet. 31:2001;497-509.
49. Quintero-Del-Rio A.I., Kelly J.A., Kilpatrick J., James J.A., Harley J.B. The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3). Genes Immun. 3(Suppl. 1):2002;S57-S62.
50. Reich D.E., Gabriel S.B., Altshuler D. Quality and completeness of SNP databases. Nat Genet. 33:2003;457-458.
51. Risch N. Corrections to "Linkage strategies for genetically complex traits: III. The effect of marker polymorphism on analysis of affected relative pairs" Am. J. Hum. Genet. 51:1992;673-675.
52. Risch N.J. Searching for genetic determinants in the new millennium. Nature. 405:2000;847-856.
53. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
54. Risch N., Teng J. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases: I. DNA pooling. Genome Res. 8:1998;1273-1288.
55. Rubio J.P., Bahlo M., Butzkueven H., van Der Mei I.A., Sale M.M., Dickinson J.L.et al. Genetic dissection of the human leukocyte antigen region by use of haplotypes of tasmanians with multiple sclerosis. Am. J. Hum. Genet. 70:2002;1125-1137.
56. Sachidanandam R., Weissman D., Schmidt S.C., Kakol J.M., Stein L.D., Marth G.et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 409:2001;928-933.
57. Sadovnick A.D., Armstrong H., Rice G.P., Bulman D., Hashimoto L., Paty D.W.et al. A population-based study of multiple sclerosis in twins: update. Ann. Neurol. 33:1993;281-285.
58. Sadovnick A.D., Ebers G.C., Dyment D.A., Risch N.J. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet. 347:1996;1728-1730.
59. Salisbury B.A., Pungliya M., Choi J.Y., Jiang R., Sun X.J., Stephens J.C. SNP and haplotype variation in the human genome. Mutat. Res. 526:2003;53-61.
60. Sawcer S., Compston A. The Genetic Analysis of Multiple sclerosis in EuropeanS (GAMES): concepts and design. J. Neuroimmunol. 143:2003;13-16. (this issue).
61. Sawcer S., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J.et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 [see comments]. Nat. Genet. 13:1996;464-468.
62. Sawser S., Maranian M., Setakis E., Curwen V., Akesson E., Hensiek A.et al. A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility. Brain. 125:2002;1337-1347.
63. Scofield R.H., Bruner G.R., Kelly J.A., Kilpatrick J., Bacino D., Nath S.K., Harley J.B. Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13. Blood. 101:2003;992-997.
64. Setakis E. Statistical analysis of the GAMES studies. J. Neuroimmunol. 143:2003;47-52. (this issue).
65. Sham P., Bader J.S., Craig I., O'Donovan M., Owen M. DNA pooling: a tool for large-scale association studies. Nat. Rev., Genet. 3:2002;862-871.
66. Stephens J.C., Schneider J.A., Tanguay D.A., Choi J., Acharya T., Stanley S.E.et al. Haplotype variation and linkage disequilibrium in 313 human genes. Science. 293:2001;489-493.
67. Subramanian G., Adams M.D., Venter J.C., Broder S. Implications of the human genome for understanding human biology and medicine. Jama. 286:2001;2296-2307.
68. Thomson G. Mapping disease genes: family-based association studies. Am. J. Hum. Genet. 57:1995;487-498.
69. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.et al. The sequence of the human genome. Science. 291:2001;1304-1351.
70. Villoslada P., Barcellos L.F., Rio J., Begovich A.B., Tintore M., Sastre-Garriga J.et al. The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta. J. Neuroimmunol. 130:2002;194-201.
71. Weinshenker B.G. The natural history of multiple sclerosis. Neurol. Clin. 13:1995;119-146.
72. Weinshenker B.G. The natural history of multiple sclerosis: update 1998. Semin. Neurol. 18:1998;301-307.
73. Weinshenker B.G., Santrach P., Bissonet A.S., McDonnell S.K., Schaid D., Moore S.B., Rodriguez M. Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study [see comments]. Neurology. 51:1998;742-747.
74. Williams N.M., Spurlock G., Norton N., Williams H.J., Hamshere M.L., Krawczak M.et al. Mutation screening and LD mapping in the VCFS deleted region of chromosome 22q11 in schizophrenia using a novel DNA pooling approach. Mol. Psychiatry. 7:2002;1092-1100.
75. Wise L.H., Lanchbury J.S., Lewis C.M. Meta-analysis of genome searches. Ann. Hum. Genet. 63:1999;263-272.
76. Xiong M., Jin L. Comparison of the power and accuracy of biallelic and microsatellite markers in population-based gene-mapping methods. Am. J. Hum. Genet. 64:1999;629-640.